Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal

NCT05050825 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

470

Enrollment

OTHER

Sponsor class

Conditions

Malaria
Dengue
Influenza -Like Illness
Diarrhea
Pneumonia
Acute Febrile Illness

Interventions

OTHER: Patient clinical management based on the CDSA strategy

Sponsor

Foundation for Innovative New Diagnostics, Switzerland

Collaborators

[object Object]
[object Object]